Unknown

Dataset Information

0

Positive Association between APOA5 rs662799 Polymorphism and Coronary Heart Disease: A Case-Control Study and Meta-Analysis.


ABSTRACT:

Objective

Apolipoprotein A5 (APOA5) is associated with plasma triglyceride (TG) levels, a risk factor for coronary heart disease (CHD). This study explored the association between CHD and the APOA5 rs662799 polymorphism.

Methods

We collected 1,521 samples (783 CHD patients and 738 controls) for this case-control study. Meta-analysis was performed using Review Manager Software and Stata Software.

Results

Significant differences were observed between CHD cases and controls at the level of both genotype (?2 = 8.964, df = 2, P = 0.011) and allele (?2 = 9.180, df = 1, P = 0.002, OR = 1.275, 95% CI = 1.089-1.492). A breakdown analysis by gender showed a significant association of APOA5 rs662799 with CHD in males (?2 = 7.770, df = 1, P = 0.005; OR = 1.331, 95% CI = 1.088-1.628). An additional meta-analysis using 21378 cases and 28428 controls established that rs662799 is significantly associated with CHD (P < 0.00001).

Conclusion

Both our case-control study and meta-analysis confirm a significant association between APOA5 rs662799 and CHD. In addition, our results suggest a male-specific association between the APOA5 rs662799 polymorphism and CHD.

SUBMITTER: Ye H 

PROVIDER: S-EPMC4550406 | BioStudies | 2015-01-01

REPOSITORIES: biostudies

Similar Datasets

2020-01-01 | S-EPMC7426633 | BioStudies
2016-01-01 | S-EPMC5054624 | BioStudies
2014-01-01 | S-EPMC3972990 | BioStudies
2018-01-01 | S-EPMC5759188 | BioStudies
2014-01-01 | S-EPMC4196964 | BioStudies
2018-01-01 | S-EPMC5900548 | BioStudies
2013-01-01 | S-EPMC3981035 | BioStudies
2018-01-01 | S-EPMC5792258 | BioStudies
2017-01-01 | S-EPMC5706800 | BioStudies
2016-01-01 | S-EPMC5101796 | BioStudies